ArticleBJU international2015

Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH).

Michael A Kozminski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.